Search research articles
Contact Us
Filters
Showing results (71-80 of 323) with videos related to
Page
of 33
Sort By:
Oncology
|
June 14, 2014
TP53 mutations in advanced colorectal cancer: the dark side of the moon
Filippo Pietrantonio, Pamela Biondani, Federica Perrone, et al.
Cancers
|
September 27, 2014
Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimens
Antonia Martinetti, Rosalba Miceli, Elisa Sottotetti, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
November 15, 2024
Liver Transplantation for Intrahepatic Cholangiocarcinoma After Chemotherapy and Radioembolization: An Intention-To-Treat Study
Marianna Maspero, Carlo Sposito, Marco A Bongini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2025
Progression-free survival as a surrogate for overall survival in gastro-esophageal cancer trials with immunotherapy: A meta-analysis
Alberto Giovanni Leone, Fausto Petrelli, Samuel J Klempner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 13, 2015
Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis
Filippo Pietrantonio, Fausto Petrelli, Andrea Coinu, et al.
Critical Reviews in Oncology/Hematology
|
February 25, 2016
Second-line angiogenesis inhibition in metastatic colorectal cancer patients: Straightforward or overcrowded?
Riccardo Giampieri, Marta Caporale, Filippo Pietrantonio, et al.
EMBO Molecular Medicine
|
July 20, 2018
miR-205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling
Cristina Migliore, Elena Morando, Elena Ghiso, et al.
Therapeutic Advances in Medical Oncology
|
November 16, 2020
Practical considerations in the use of regorafenib in metastatic colorectal cancer
Fotios Loupakis, Lorenzo Antonuzzo, Jean-Baptiste Bachet, et al.
International Journal of Cancer
|
February 24, 2015
Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab
Valeria Musella, Filippo Pietrantonio, Eleonora Di Buduo, et al.
European Radiology Experimental
|
August 26, 2024
Non-invasive CT radiomic biomarkers predict microsatellite stability status in colorectal cancer: a multicenter validation study
Zuhir Bodalal, Eun Kyoung Hong, Stefano Trebeschi, et al.
Page
of 33
Search research articles
Search
Showing results (71-80 of 323) with videos related to
Sort By:
Page
of 33
Oncology
|
June 14, 2014
TP53 mutations in advanced colorectal cancer: the dark side of the moon
Filippo Pietrantonio, Pamela Biondani, Federica Perrone, et al.
Cancers
|
September 27, 2014
Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimens
Antonia Martinetti, Rosalba Miceli, Elisa Sottotetti, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
November 15, 2024
Liver Transplantation for Intrahepatic Cholangiocarcinoma After Chemotherapy and Radioembolization: An Intention-To-Treat Study
Marianna Maspero, Carlo Sposito, Marco A Bongini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2025
Progression-free survival as a surrogate for overall survival in gastro-esophageal cancer trials with immunotherapy: A meta-analysis
Alberto Giovanni Leone, Fausto Petrelli, Samuel J Klempner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 13, 2015
Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis
Filippo Pietrantonio, Fausto Petrelli, Andrea Coinu, et al.
Critical Reviews in Oncology/Hematology
|
February 25, 2016
Second-line angiogenesis inhibition in metastatic colorectal cancer patients: Straightforward or overcrowded?
Riccardo Giampieri, Marta Caporale, Filippo Pietrantonio, et al.
EMBO Molecular Medicine
|
July 20, 2018
miR-205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling
Cristina Migliore, Elena Morando, Elena Ghiso, et al.
Therapeutic Advances in Medical Oncology
|
November 16, 2020
Practical considerations in the use of regorafenib in metastatic colorectal cancer
Fotios Loupakis, Lorenzo Antonuzzo, Jean-Baptiste Bachet, et al.
International Journal of Cancer
|
February 24, 2015
Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab
Valeria Musella, Filippo Pietrantonio, Eleonora Di Buduo, et al.
European Radiology Experimental
|
August 26, 2024
Non-invasive CT radiomic biomarkers predict microsatellite stability status in colorectal cancer: a multicenter validation study
Zuhir Bodalal, Eun Kyoung Hong, Stefano Trebeschi, et al.
Page
of 33